• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Infect Dis . The RdRp genotyping of SARS-CoV-2 isolated from patients with different clinical spectrum of COVID-19

tetano

Editor, Senior Moderator
BMC Infect Dis


. 2024 Mar 4;24(1):281.
doi: 10.1186/s12879-024-09146-x. The RdRp genotyping of SARS-CoV-2 isolated from patients with different clinical spectrum of COVID-19

Michał Majchrzak[SUP] 1 [/SUP], Łukasz Madej[SUP] 1 [/SUP], Małgorzata Łysek-Gładysińska[SUP] 2 [/SUP], Dorota Zarębska-Michaluk[SUP] 1 [/SUP], Katarzyna Zegadło[SUP] 1 [/SUP], Anna Dziuba[SUP] 1 [/SUP], Katarzyna Nogal-Nowak[SUP] 3 [/SUP], Wioleta Kondziołka[SUP] 4 [/SUP], Iwona Sufin[SUP] 5 [/SUP], Mieczysława Myszona-Tarnowska[SUP] 6 [/SUP], Mateusz Jaśkowski[SUP] 7 [/SUP], Mateusz Kędzierski[SUP] 7 [/SUP], Jadwiga Maciukajć[SUP] 8 [/SUP], Jarosław Matykiewicz[SUP] 1 [/SUP], Stanisław Głuszek[SUP] 1 [/SUP], Wioletta Adamus-Białek[SUP] 9 [/SUP]



Affiliations
Free PMC article Abstract

Background: The evolution of SARS-CoV-2 has been observed from the very beginning of the fight against COVID-19, some mutations are indicators of potentially dangerous variants of the virus. However, there is no clear association between the genetic variants of SARS-CoV-2 and the severity of COVID-19. We aimed to analyze the genetic variability of RdRp in correlation with different courses of COVID-19.
Results: The prospective study included 77 samples of SARS-CoV-2 isolated from outpatients (1st degree of severity) and hospitalized patients (2nd, 3rd and 4th degree of severity). The retrospective analyses included 15,898,266 cases of SARS-CoV-2 genome sequences deposited in the GISAID repository. Single-nucleotide variants were identified based on the four sequenced amplified fragments of SARS-CoV-2. The analysis of the results was performed using appropriate statistical methods, with p < 0.05, considered statistically significant. Additionally, logistic regression analysis was performed to predict the strongest determinants of the observed relationships. The number of mutations was positively correlated with the severity of the COVID-19, and older male patients. We detected four mutations that significantly increased the risk of hospitalization of COVID-19 patients (14676C > T, 14697C > T, 15096 T > C, and 15279C > T), while the 15240C > T mutation was common among strains isolated from outpatients. The selected mutations were searched worldwide in the GISAID database, their presence was correlated with the severity of COVID-19.
Conclusion: Identified mutations have the potential to be used to assess the increased risk of hospitalization in COVID-19 positive patients. Experimental studies and extensive epidemiological data are needed to investigate the association between individual mutations and the severity of COVID-19.

Keywords: RdRp; SARS-CoV-2; Severity of COVID-19.

 
Back
Top Bottom